Literature DB >> 29225041

Syringaresinol suppresses excitatory synaptic transmission and picrotoxin-induced epileptic activity in the hippocampus through presynaptic mechanisms.

Young Seon Cho1, Woo Seok Song1, Sang Ho Yoon1, Kyeong-Yeol Park1, Myoung-Hwan Kim2.   

Abstract

Many neuromodulating drugs acting on the nervous system originate from botanical sources. These plant-derived substances modulate the activity of receptors, ion channels, or transporters in neurons. Their properties make the substances useful for medicine and research. Here, we show that the plant lignan (+)-syringaresinol (SYR) suppresses excitatory synaptic transmission via presynaptic modulation. Bath application of SYR rapidly reduced the slopes of the field excitatory postsynaptic potentials (fEPSPs) at the hippocampal Schaffer collateral (SC)-CA1 synapse in a dose-dependent manner. SYR preferentially affected excitatory synapses, while inhibitory synaptic transmission remained unchanged. SYR had no effect on the conductance or the desensitization of AMPARs but increased the paired-pulse ratios of synaptic responses at short (20-200 ms) inter-stimulus intervals. These presynaptic changes were accompanied by a reduction of the readily releasable pool size. Pretreatment of hippocampal slices with the Gi/o protein inhibitor N-ethylmaleimide (NEM) abolished the effect of SYR on excitatory synaptic transmission, while the application of SYR significantly decreased Ca2+ currents and hyperpolarized the resting membrane potentials of hippocampal neurons. In addition, SYR suppressed picrotoxin-induced epileptiform activity in hippocampal slices. Overall, our study identifies SYR as a new neuromodulating agent and suggests that SYR suppresses excitatory synaptic transmission by modulating presynaptic transmitter release.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiepileptic activity; Excitatory synapse; Presynaptic suppression; Readily releasable pool; Syringaresinol

Mesh:

Substances:

Year:  2017        PMID: 29225041     DOI: 10.1016/j.neuropharm.2017.12.014

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

1.  Syringaresinol Resisted Sepsis-Induced Acute Lung Injury by Suppressing Pyroptosis Via the Oestrogen Receptor-β Signalling Pathway.

Authors:  Yuzhen Zhuo; Lei Yang; Dihua Li; Lanqiu Zhang; Qi Zhang; Shukun Zhang; Caixia Li; Lihua Cui; Jian Hao; Jiarui Li; Ximo Wang
Journal:  Inflammation       Date:  2021-11-22       Impact factor: 4.092

2.  Altered hippocampal gene expression, glial cell population, and neuronal excitability in aminopeptidase P1 deficiency.

Authors:  Sang Ho Yoon; Young-Soo Bae; Sung Pyo Oh; Woo Seok Song; Hanna Chang; Myoung-Hwan Kim
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

3.  Attenuation of inflammatory responses by (+)-syringaresinol via MAP-Kinase-mediated suppression of NF-κB signaling in vitro and in vivo.

Authors:  Vivek K Bajpai; Md Badrul Alam; Khong Trong Quan; Mi-Kyoung Ju; Rajib Majumder; Shruti Shukla; Yun Suk Huh; MinKyun Na; Sang Han Lee; Young-Kyu Han
Journal:  Sci Rep       Date:  2018-06-15       Impact factor: 4.379

4.  Combination of syringaresinol-di-O-β-D-glucoside and chlorogenic acid shows behavioral pharmacological anxiolytic activity and activation of hippocampal BDNF-TrkB signaling.

Authors:  Shouhei Miyazaki; Yoshio Fujita; Hirotaka Oikawa; Hideo Takekoshi; Hideaki Soya; Masato Ogata; Takahiko Fujikawa
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.